Progyny, Inc. Announces Second Quarter 2024 Results

Go back to Progyny, Inc. Announces Second Quarter 2024 Results

Progyny (PGNY) PT Lowered to $33 at Truist Securities

August 7, 2024 6:30 AM EDT

Truist Securities analyst Jailendra Singh lowered the price target on Progyny (NASDAQ: PGNY) to $33.00 (from $37.00) while maintaining a Buy rating.

The analyst comments "We had a post-quarterly conference call with PGNY management to discuss 2Q24 results, ART cycles per utilizer trends, its 2024... More

BTIG Downgrades Progyny (PGNY) to Neutral

August 7, 2024 5:23 AM EDT

BTIG analyst David Larsen downgraded Progyny (NASDAQ: PGNY) from Buy to Neutral.

The analyst comments "We are downgrading Progyny (PGNY) to Neutral, following the company's 2Q:24 earnings report. 2Q24 revenue of $304.1M compares to BTIG / consensus of $306.5M / $305M, and EBITDA of $54.5M compares to BTIG / consensus of $53M/ $53M. Despite the... More